BridgeBio Pharma (BBIO) EBITDA Margin Growth (1y) (2020 - 2026)
BridgeBio Pharma (BBIO) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | 3,502.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,502.00 |
| Dec 31, 2025 | 375,217.00 |
| Sep 30, 2025 | 689,837.00 |
| Jun 30, 2025 | 797,537.00 |
| Mar 31, 2025 | -8,965.00 |
| Dec 31, 2024 | 632,442.00 |
| Sep 30, 2024 | -316,406.00 |
| Jun 30, 2024 | 80,623.00 |
| Mar 31, 2024 | 690,942.00 |
| Dec 31, 2023 | -325,630.00 |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | -879,433.00 |
| Mar 31, 2023 | 334,328.00 |
| Dec 31, 2022 | -525,466.00 |
| Sep 30, 2022 | -3.18 Mn |
| Jun 30, 2022 | 6,531.00 |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 10.28 Mn |
| Sep 30, 2021 | -490,213.00 |
| Sep 30, 2020 | -127,157.00 |